跳至主要内容
临床试验/NCT01948219
NCT01948219终止不适用

An Evaluation of the ENTegral Artificial Larynx (AL) in Patients Indicated for Total Laryngectomy

ProTiP Medical6 个研究点 分布在 2 个国家目标入组 2 人开始时间: 2014年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
2
试验地点
6
主要终点
Feasibility of device implant procedure

研究概览

简要总结

The objective of this clinical study is to evaluate the feasibility, safety and efficacy of the ENTegral Artificial Larynx (AL) in patients indicated for total laryngectomy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age more than or equal to 18 years old
  • Is indicated for total laryngectomy (first intention)
  • Must be able to comply with study requirements
  • Must be able to understand and be willing to provide written informed consent

排除标准

  • Any condition that precludes the implantation of the ENTegral AL
  • Existing coagulation disorder
  • Contraindication for general anesthesia
  • Tumoral extension outside of the larynx invading through extra-laryngeal structures
  • Previous radiotherapy
  • Life-expectancy < 12 months
  • Be pregnant of breastfeeding or intention to becoming pregnant during study

研究组 & 干预措施

ENTegral Artificial Larynx implant

Experimental

ENTegral Artificial Larynx implantation

干预措施: ENTegral Artificial Larynx implant (Device)

结局指标

主要结局

Feasibility of device implant procedure

时间窗: 1 year

Number of patients with adverse event associated with device implantation procedure

次要结局

未报告次要终点

研究者

发起方
ProTiP Medical
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验